Germany · Delayed Price · Currency is EUR Mochida Pharmaceutical Statistics
Total Valuation
FRA:MFY has a market cap or net worth of EUR 734.17 million. The enterprise value is 561.60 million.
| Market Cap | 734.17M |
| Enterprise Value | 561.60M |
Important Dates
The last earnings date was Friday, February 6, 2026.
| Earnings Date | Feb 6, 2026 |
| Ex-Dividend Date | Sep 29, 2025 |
Share Statistics
| Current Share Class | 35.45M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 23.20M |
Valuation Ratios
The trailing PE ratio is 21.05.
| PE Ratio | 21.05 |
| Forward PE | n/a |
| PS Ratio | 1.21 |
| PB Ratio | 0.98 |
| P/TBV Ratio | 0.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 16.10 |
| EV / Sales | 0.92 |
| EV / EBITDA | 8.98 |
| EV / EBIT | 12.23 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.01, with a Debt / Equity ratio of 0.07.
| Current Ratio | 4.01 |
| Quick Ratio | 2.72 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 271.29 |
Financial Efficiency
Return on equity (ROE) is 4.80% and return on invested capital (ROIC) is 8.48%.
| Return on Equity (ROE) | 4.80% |
| Return on Assets (ROA) | 3.02% |
| Return on Invested Capital (ROIC) | 8.48% |
| Return on Capital Employed (ROCE) | 5.53% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 403,145 |
| Profits Per Employee | 23,134 |
| Employee Count | 1,508 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 1.67 |
Taxes
In the past 12 months, FRA:MFY has paid 12.75 million in taxes.
| Income Tax | 12.75M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.62% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +4.62% |
| 50-Day Moving Average | 19.26 |
| 200-Day Moving Average | 18.02 |
| Relative Strength Index (RSI) | 55.17 |
| Average Volume (20 Days) | 2 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:MFY had revenue of EUR 607.94 million and earned 34.89 million in profits. Earnings per share was 0.98.
| Revenue | 607.94M |
| Gross Profit | 294.41M |
| Operating Income | 45.68M |
| Pretax Income | 47.64M |
| Net Income | 34.89M |
| EBITDA | 62.19M |
| EBIT | 45.68M |
| Earnings Per Share (EPS) | 0.98 |
Balance Sheet
The company has 225.42 million in cash and 54.32 million in debt, with a net cash position of 171.10 million.
| Cash & Cash Equivalents | 225.42M |
| Total Debt | 54.32M |
| Net Cash | 171.10M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 746.54M |
| Book Value Per Share | 21.06 |
| Working Capital | 491.41M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 7.51% |
| Pretax Margin | 7.84% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.47, which amounts to a dividend yield of 2.33%.
| Dividend Per Share | 0.47 |
| Dividend Yield | 2.33% |
| Dividend Growth (YoY) | -3.47% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | 2.33% |
| Earnings Yield | 4.75% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 27, 2019. It was a forward split with a ratio of 2.
| Last Split Date | Mar 27, 2019 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |